Cargando…

Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys® vascular access system

Introduction: The aim of this study is to report our clinical hemodialysis experience using a percutaneous arteriovenous fistula (pAVF) created with the Ellipsys® vascular access system. This pAVF device creates a permanent AVF anastomosis between the proximal radial artery (PRA) and the deep commun...

Descripción completa

Detalles Bibliográficos
Autores principales: Hebibi, Hedia, Achiche, Jedjiga, Franco, Gilbert, Rottembourg, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850632/
https://www.ncbi.nlm.nih.gov/pubmed/30821894
http://dx.doi.org/10.1111/hdi.12738
_version_ 1783469467253080064
author Hebibi, Hedia
Achiche, Jedjiga
Franco, Gilbert
Rottembourg, Jacques
author_facet Hebibi, Hedia
Achiche, Jedjiga
Franco, Gilbert
Rottembourg, Jacques
author_sort Hebibi, Hedia
collection PubMed
description Introduction: The aim of this study is to report our clinical hemodialysis experience using a percutaneous arteriovenous fistula (pAVF) created with the Ellipsys® vascular access system. This pAVF device creates a permanent AVF anastomosis between the proximal radial artery (PRA) and the deep communicating vein (DCV) in the proximal forearm. Methods: The medical records of all patients with a pAVF were retrospectively reviewed. The clinical data analyzed included reliability of pAVF use, quality of dialysis, rate and success of puncture, and pAVF related complications, along with incidence of subsequent interventions. Findings: Between May 2017 and November 2018, 34 patients had a pAVF created with technical success in 33 patients (97%). Twenty‐eight out of 34 (82%) patients had successful two‐needle cannulation within 10 days to 6 weeks after pAVF creation. The mean Kt/v was 1.6 (1.2‐2) and the average recirculation was 10%. Fifteen patients (44%) needed no further access intervention. Twelve patients (35%) required an additional procedure to assist maturation of the pAVF in order to facilitate puncture. The average blood flow measured at the brachial artery, before the first cannulation, was 850 ml/min. From causes unrelated to the procedure, four patients died during the follow‐up study. Two patients required revision to a surgical AVF. None of the pAVFs developed aneurysmal degeneration steal syndrome, or high access flow related issues. Discussion: The Ellipsys® pAVF offers a safe and functional vascular access for hemodialysis. Advantages included prompt access maturation, avoidance of high flow AVFs, and a simple nonsurgical procedure with high patient satisfaction. Functional outcomes are equivalent and likely better than surgical fistulas. There appears to be less aneurysmal degeneration and need for future re‐intervention. Objective dialysis parameters indicate excellent quality of hemodialysis for the patient.
format Online
Article
Text
id pubmed-6850632
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-68506322019-11-18 Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys® vascular access system Hebibi, Hedia Achiche, Jedjiga Franco, Gilbert Rottembourg, Jacques Hemodial Int Original Articles Introduction: The aim of this study is to report our clinical hemodialysis experience using a percutaneous arteriovenous fistula (pAVF) created with the Ellipsys® vascular access system. This pAVF device creates a permanent AVF anastomosis between the proximal radial artery (PRA) and the deep communicating vein (DCV) in the proximal forearm. Methods: The medical records of all patients with a pAVF were retrospectively reviewed. The clinical data analyzed included reliability of pAVF use, quality of dialysis, rate and success of puncture, and pAVF related complications, along with incidence of subsequent interventions. Findings: Between May 2017 and November 2018, 34 patients had a pAVF created with technical success in 33 patients (97%). Twenty‐eight out of 34 (82%) patients had successful two‐needle cannulation within 10 days to 6 weeks after pAVF creation. The mean Kt/v was 1.6 (1.2‐2) and the average recirculation was 10%. Fifteen patients (44%) needed no further access intervention. Twelve patients (35%) required an additional procedure to assist maturation of the pAVF in order to facilitate puncture. The average blood flow measured at the brachial artery, before the first cannulation, was 850 ml/min. From causes unrelated to the procedure, four patients died during the follow‐up study. Two patients required revision to a surgical AVF. None of the pAVFs developed aneurysmal degeneration steal syndrome, or high access flow related issues. Discussion: The Ellipsys® pAVF offers a safe and functional vascular access for hemodialysis. Advantages included prompt access maturation, avoidance of high flow AVFs, and a simple nonsurgical procedure with high patient satisfaction. Functional outcomes are equivalent and likely better than surgical fistulas. There appears to be less aneurysmal degeneration and need for future re‐intervention. Objective dialysis parameters indicate excellent quality of hemodialysis for the patient. John Wiley & Sons, Inc. 2019-03-01 2019-04 /pmc/articles/PMC6850632/ /pubmed/30821894 http://dx.doi.org/10.1111/hdi.12738 Text en © 2019 The Authors. Hemodialysis International published by Wiley Periodicals, Inc. on behalf of International Society for Hemodialysis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Hebibi, Hedia
Achiche, Jedjiga
Franco, Gilbert
Rottembourg, Jacques
Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys® vascular access system
title Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys® vascular access system
title_full Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys® vascular access system
title_fullStr Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys® vascular access system
title_full_unstemmed Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys® vascular access system
title_short Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys® vascular access system
title_sort clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the ellipsys® vascular access system
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850632/
https://www.ncbi.nlm.nih.gov/pubmed/30821894
http://dx.doi.org/10.1111/hdi.12738
work_keys_str_mv AT hebibihedia clinicalhemodialysisexperiencewithpercutaneousarteriovenousfistulascreatedusingtheellipsysvascularaccesssystem
AT achichejedjiga clinicalhemodialysisexperiencewithpercutaneousarteriovenousfistulascreatedusingtheellipsysvascularaccesssystem
AT francogilbert clinicalhemodialysisexperiencewithpercutaneousarteriovenousfistulascreatedusingtheellipsysvascularaccesssystem
AT rottembourgjacques clinicalhemodialysisexperiencewithpercutaneousarteriovenousfistulascreatedusingtheellipsysvascularaccesssystem